US$ 27.03
willow semaglutide tablets Willow's so-called bootlegged “semaglutide tablets” are not FDA-approved drugs, and the company has not published verified ingredient data in any peer-reviewed or regulatory source. Because these formulations are unregulated compounded products, neither 1 receptor agonist). Willow GLP-1 Review 2026: Flat
Description
In December 2024, 1.9 million prescriptions of GLP-1s to treat obesity (as opposed to diabetes, for example) were filled, nearly quadruple the number YoY, per IQVIA

Not the Australian TGA

Many insurers now cover Mounjaro, but only if you have a diagnosis of type 2 diabetes.

& McLaughlin, T
doi: 10.1016/j.biopha.2019.109015 [DOI] [PubMed] [Google Scholar] 37.Hatwal A

Namazi N, Larijani B, Ayati MH, et al
